Autopsy report · NCT06138327

A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

“The study was withdrawn because BioMarin decided to end the overall development program. The study withdrawal was not due to any patient safety concerns.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

BioMarin Pharmaceutical

Sponsor type

Industry

Conditions

Hyperoxaluria; Nonalcoholic Fatty Liver Disease; Kidney Stone

Interventions

BMN 255; Placebo

Participants

0

Sites

7

Countries

United States

Trials that died the same way

• Medication Use Among American Indians Adults
  “The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.” (73% match in meaning)
• A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
  “Study was withdrawn due to scientific and business considerations.” (72% match in meaning)
• Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
  “US FDA is streamlining the Biosimilar development. Thus, Biocon decided to terminate the study.” (70% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (70% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.